Why the study?
Progressive atherosclerosis leads to unfavorable clinical outcomes, necessitating study of coronary artery lesion dynamics in patients with multiple ischemic events.
Observational (n=51)
Odds Ratio: 6.349 (95% CI 2.548–15.823)
In patients with recurrent MI and a history of multiple ischemic events, coronary stenosis consistently progresses, and a SYNTAX Score > 22.5 strongly predicts one-year adverse outcomes.
Вackground. Progressive atherosclerosis is accompanied by unfavorable clinical outcomes; study and understanding of this process is necessary to identify the appropriate risk groups. Purpose of the study to study the dynamics of atherosclerotic lesions of the coronary arteries in patients with several ischemic events in history. Patient Characterization and Research Methods. The present subanalysis included 51 patients with recurrent nonfatal myocardial infarction (MI) out of the initially included 100 patients with index MI. All 100 patients had a history of two or more ischemic coronary or cerebral events, which corresponds to the clinical signs of progressive atherosclerosis. The dynamics of the degree of coronary stenosis from the moment of index MI to repeated MI was assessed according to the data of selective coronary angiography. The statistical program Microsoft Office Excel 2019 was used. Results. All patients with recurrent myocardial infarction (51 people) had signs of progression of coronary artery stenosis: "mild" progression - 82.3%, "moderate" and "severe" - 15.6% and 2.1%, respectively. SYNTAX Score> 22.5 points was a predictor of one-year adverse outcomes: OR 6.349, CI (2.548-15.823). The results obtained make it possible to distinguish a group of patients with accelerated atherosclerosis syndrome in order to stratify the risk and optimally manage this complex category of patients.
No takes yet. Share an insight, caveat, or question.
Parkhomenko et al. (2021) conducted an observational in Recurrent nonfatal myocardial infarction (n=51). SYNTAX Score > 22.5 points was evaluated on one-year adverse outcomes (OR 6.349, 95% CI 2.548-15.823).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: